Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration ...Middle East

In the preliminary findings of a study conducted with the National Taiwan University Hospital, over 50% of sample cases were reclassified as HER2-expressing when 3D pathology was applied. HSINCHU, April 16, 2025 /PRNewswire/ -- JelloX Biotech Inc., a Taiwan-based startup at the forefront...

Read More Details
Finally We wish PressBee provided you with enough information of ( Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration )

Also on site :

• Assault suspect shot by police at Morgan Hill Safeway
• Sean ‘Diddy’ Combs Loses Bid to Delay Sex Trafficking Trial
• ‘He’s got MS-13 tattooed onto his knuckles’: Trump appears to hold up photoshopped image of Abrego Garcia’s hand